Cell Transformation, Neoplastic

"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Descriptor ID	D002471
MeSH Number(s)	C04.697.098.500 C23.550.727.098.500
Concept/Terms	Cell Transformation, Neoplastic Cell Transformation, Neoplastic Tumorigenic Transformation Transformation, Tumorigenic Transformations, Tumorigenic Tumorigenic Transformations Transformation, Neoplastic Cell Neoplastic Cell Transformation Cell Transformations, Neoplastic Neoplastic Cell Transformations Transformations, Neoplastic Cell Neoplastic Transformation, Cell Cell Neoplastic Transformation Cell Neoplastic Transformations Neoplastic Transformations, Cell Transformation, Cell Neoplastic Transformations, Cell Neoplastic

Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".

Diseases [C]
Neoplasms [C04]
Neoplastic Processes [C04.697]
Carcinogenesis [C04.697.098]
Cell Transformation, Neoplastic [C04.697.098.500]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Neoplastic Processes [C23.550.727]
Carcinogenesis [C23.550.727.098]
Cell Transformation, Neoplastic [C23.550.727.098.500]

Below are MeSH descriptors whose meaning is related to "Cell Transformation, Neoplastic".

Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".

Cell Transformation, Neoplastic
Blast Crisis
Cell Transformation, Viral

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.

Bar chart showing 80 publications over 25 distinct years, with a maximum of 9 publications in 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	1	0	1
1992	0	1	1
1994	1	0	1
1995	2	0	2
1998	0	1	1
1999	1	0	1
2002	1	1	2
2003	0	1	1
2004	3	0	3
2005	1	1	2
2006	1	2	3
2007	4	4	8
2008	3	2	5
2009	2	0	2
2010	0	1	1
2011	2	0	2
2012	3	3	6
2013	1	3	4
2014	2	4	6
2015	5	4	9
2016	4	5	9
2017	1	1	2
2018	5	1	6
2019	0	1	1
2020	0	1	1

Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.

Moore LL, Zhou Z, Li M, Houchen CW. Tuft Cells Play Critical Roles in the Heterogeneity and Epithelial Plasticity in Pancreatic Cancer Initiation and Progression. Gastroenterology. 2020 11; 159(5):1657-1659.

View in: PubMed
Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, Zhang S, Zhang Z, Kong X, Xu Q, He F, Bai X, Sun B, Hung MC, Liu L, Wands J, Dong X. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019 11 07; 18(1):156.

View in: PubMed
Borga C, Foster CA, Iyer S, Garcia SP, Langenau DM, Frazer JK. Molecularly distinct models of zebrafish Myc-induced B cell leukemia. Leukemia. 2019 02; 33(2):559-562.

View in: PubMed
Dmello C, Sawant S, Chaudhari PR, Dongre H, Ahire C, D'Souza ZC, Charles SE, Rane P, Costea DE, Chaukar D, Kane S, Vaidya M. Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation. Exp Mol Pathol. 2018 12; 105(3):243-251.

View in: PubMed
Yarla NS, Gali H, Pathuri G, Smriti S, Farooqui M, Panneerselvam J, Kumar G, Madka V, Rao CV. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention. Semin Cancer Biol. 2019 06; 56:168-174.

View in: PubMed
Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah R, Hasan A, Ahmed ST, Bresolin S, Batchelor L, Scordino T, Miles RR, Te Kronnie G, Regens JL, Frazer JK. Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2019 02; 33(2):333-347.

View in: PubMed
Ma Z, Kim YM, Howard EW, Feng X, Kosanke SD, Yang S, Jiang Y, Parris AB, Cao X, Li S, Yang X. DMBA promotes ErbB2-mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncol Rep. 2018 Sep; 40(3):1632-1640.

View in: PubMed
Ge Y, Weygant N, Qu D, May R, Berry WL, Yao J, Chandrakesan P, Zheng W, Zhao L, Zhao KL, Drake M, Vega KJ, Bronze MS, Tomasek JJ, An G, Houchen CW. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer. Int J Cancer. 2018 09 01; 143(5):1162-1175.

View in: PubMed
Deswaerte V, Nguyen P, West A, Browning AF, Yu L, Ruwanpura SM, Balic J, Livis T, Girard C, Preaudet A, Oshima H, Fung KY, Tye H, Najdovska M, Ernst M, Oshima M, Gabay C, Putoczki T, Jenkins BJ. Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism. Cancer Res. 2018 03 01; 78(5):1293-1307.

View in: PubMed
Choi J, Xu M, Makowski MM, Zhang T, Law MH, Kovacs MA, Granzhan A, Kim WJ, Parikh H, Gartside M, Trent JM, Teulade-Fichou MP, Iles MM, Newton-Bishop JA, Bishop DT, MacGregor S, Hayward NK, Vermeulen M, Brown KM. A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF. Nat Genet. 2017 Sep; 49(9):1326-1335.

View in: PubMed

People

Explore

Similar Concepts

Top Journals